|
|
|
|
|
|||
GBR 2010
COI 14.29 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
GBR 1999
COI 3.52 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
-
6/2/2024
Degenerative myelopathy (DM)
N/N (clear)
-
6/2/2024
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
6/2/2024
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
6/2/2024
Year of death:
2016
|
||
GBR 2008
COI 2.44 %
*
Breed relevant health information:
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
|||
|
GBR 2012
COI 0.62 %
*
Breed relevant health information:
Hips
Mild / C2 / 13-18 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
GBR 2004
COI 2.09 %
*
Breed relevant health information:
Elbows
normal
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
FIN 2005
COI 3.52 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
21/9/2006
|
|||
|
FIN 2012
COI 2.53 %
*
Breed relevant health information:
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
25/9/2014
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Oberitz Valkea Yö
|
15 Jul 2015 | |||||||||
Oberitz Pilvilinna
|
13 Nov 2021 | |||||||||
Siblings | ||||||||||
Oberitz Valonkantaja
|
30 May 2024 | |||||||||
Oberitz Valontuojatar
|
30 May 2024 | |||||||||
Oberitz Valonvälke
|
30 May 2024 | |||||||||
Oberitz Valonvaltias
|
30 May 2024 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Offspring |